Cumming, GA, United States of America

Karen Ellis James

This inventor holds 2 USPTO granted patents. Top assignee: Georgia Tech Research Corporation. Active years: 2006-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karen Ellis James. Retrieved from https://idiyas.com/inventor/karen-ellis-james

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Karen Ellis James

Introduction

Karen Ellis James is an accomplished inventor based in Cumming, GA (US). She has made significant contributions to the field of protease inhibitors, with a focus on developing compositions that can inhibit specific proteases associated with various diseases. Her work has led to the filing of two patents that showcase her innovative approach to addressing critical health issues.

Latest Patents

Karen's latest patents include "Propenoyl Hydrazides" and "Aza-Peptide Epoxides." The patent for Propenoyl Hydrazides provides compositions for inhibiting proteases, along with methods for synthesizing these compositions and utilizing the disclosed protease inhibitors. This invention specifically targets cysteine proteases, which can be inhibited either in vivo or in vitro. The Aza-Peptide Epoxides patent similarly offers compositions for inhibiting proteases, with a focus on cysteine proteases. The disclosed compounds, including pharmaceutically acceptable salts and derivatives, are designed to treat diseases related to protease activity, such as viral infections, stroke, neurodegenerative diseases, and inflammatory conditions.

Career Highlights

Karen Ellis James is affiliated with the Georgia Tech Research Corporation, where she continues to advance her research in protease inhibitors. Her innovative work has positioned her as a key figure in the development of therapeutic solutions for complex health challenges.

Collaborations

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…